Home › Graft-Versus-Host Disease › Ohio › Columbus
Graft-Versus-Host Disease clinical trials in Columbus, OH
6 studies for Graft-Versus-Host Disease are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.
RecruitingPhase 2
- The Ohio State University, Columbus
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
RecruitingPhase 3
- Ohio State University, Columbus
Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma
RecruitingPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
RecruitingPhase 1
- Ohio State University Medical Center, Columbus
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- The Ohio State University Comprehensive Cancer Center, Columbus
Graft-Versus-Host Disease trials in other cities
- Boston, MA10 studies
- New York City, NY7 studies
- Washington, DC5 studies
- Atlanta, GA5 studies
- St. Louis, MO4 studies
- Miami, FL4 studies
- Portland, OR4 studies
- Tampa, FL4 studies
- Detroit, MI4 studies
- Seattle, WA4 studies
- Queens, NY4 studies
- Baldwin Park, CA4 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer54 studies
- Ovarian Cancer40 studies
- Breast Cancer39 studies
- Cancer (all types)39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Endometrial Cancer26 studies
- Metastatic Cancer26 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
- Colorectal Cancer23 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.